Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited have noted that Shandong Weigao Group Medical Polymer Company Limited (1066) issued an overseas regulatory announcement dated 27 February 2026. The announcement emphasizes that the organizations accept no responsibility for its content while requiring compliance with the relevant listing rules.
According to pertinent regulations of the People’s Republic of China, Shandong Weigao Orthopaedic Device Company Limited (688161) has published its announcement on the Shanghai Stock Exchange’s website. The disclosure indicates that an update is available in Chinese, and it has been released in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The board of directors of Shandong Weigao Group Medical Polymer Company Limited comprises Executive Directors Long Jing, Cong Rinan, Lu Junqiang, and Wang Daoming; Non-executive Directors Chen Lin and Tang Zhengpeng; and Independent Non-executive Directors Li Guohui, Meng Hong, Li Qiang, and Sun Heng.
Comments